Panel & Audience Discussion: Enhancing Diversity in CKD Clinical Trials: What is Needed, What is Working, & What is Next?
Time: 11:30 am
day: Day Two Track 2
Details:
- Explore initiatives that have increased participation of underrepresented groups in CKD clinical trials where these efforts have yielded more inclusive trial populations
- Discuss the importance of diverse representation in trials for generating more accurate and generalizable data ensuring that treatments are effective across all demographics
- Explore new and emerging methods for ensuring diverse trial participation, such as the use of decentralized trials, remote monitoring, and partnerships with local healthcare providers